Aclaris Therapeutics, a biopharmaceutical company focused on developing therapies to address dermatological disease, recently announced plans to expand its operations in the Cortex Innovation Community in St. Louis, Missouri. The expansion is expected to add approximately 14 new jobs to the region.
The Cortex Innovation Community was created in 2002 through an initial investment of $29 million from Washington University, BJC HealthCare, the University of Missouri – St. Louis, Saint Louis University and the Missouri Botanical Garden. It has since grown into the region’s largest innovation hub, generating more than 4,000 jobs and upward of $500 million in investment.
Cutting-edge biomedical research is taking place across Missouri, in world-renowned research hospitals, and innovation communities. Additionally, Missouri is home to some of the most prestigious hospitals, medical schools and health companies in the world.
For more information on Missouri’s health innovation industry check out our webpage, or contact Steve Johnson, CEO of Missouri Partnership, at 314.725.2688 or via our contact form. He will answer any questions you might have, and explain how Missouri Partnership can help with your business expansion and investment needs.